Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ignacio Catalan-Serra & Øystein Brenna. (2018) Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Human Vaccines & Immunotherapeutics 14:11, pages 2597-2611.
Read now
Read now
Articles from other publishers (21)
Aidan J Kelly & Aideen Long. (2023) Targeting T-cell integrins in autoimmune and inflammatory diseases. Clinical and Experimental Immunology.
Crossref
Crossref
Hannah Gordon, Beverley Rodger, James O Lindsay & Andrew J Stagg. (2023) Recruitment and Residence of Intestinal T Cells – Lessons for Therapy in Inflammatory Bowel Disease. Journal of Crohn's and Colitis.
Crossref
Crossref
Zhou Liang, Xinrong Hu, Ruoni Lin, Ziwen Tang, Ziyin Ye, Ren Mao, Wei Chen & Yi Zhou. (2023) Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis. Frontiers in Immunology 14.
Crossref
Crossref
Bhavana Bhagya Rao, Abhik Bhattacharya & Gary R. Lichtenstein. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
457
493
.
Jesus K Yamamoto-Furusho & Norma N Parra-Holguín. (2021) Emerging therapeutic options in inflammatory bowel disease. World Journal of Gastroenterology 27:48, pages 8242-8261.
Crossref
Crossref
Manish Pandey, Divya Ojha, Sakshi Bansal, Ambadas B. Rode & Geetanjali Chawla. (2021) From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases. Molecular Aspects of Medicine 81, pages 101003.
Crossref
Crossref
Elias Fattal & François Fay. (2021) Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases. Advanced Drug Delivery Reviews 175, pages 113809.
Crossref
Crossref
Stanley T. Crooke, Xue-hai Liang, Rosanne M. Crooke, Brenda F. Baker & Richard S. Geary. (2021) Antisense drug discovery and development technology considered in a pharmacological context. Biochemical Pharmacology 189, pages 114196.
Crossref
Crossref
Wunan Zhang, Cecilia Bohns Michalowski & Ana Beloqui. (2021) Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Crossref
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min & Chang Hwan Choi. (2021) Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 44:3, pages 293-309.
Crossref
Crossref
Lin Xu, Jiaqi Zhang, Yifan Wang, Zedan Zhang, Fengyun Wang & Xudong Tang. (2021) Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification. Bioscience Reports 41:2.
Crossref
Crossref
Stanley T. Crooke, Xue-Hai Liang, Brenda F. Baker & Rosanne M. Crooke. (2021) Antisense technology: A review. Journal of Biological Chemistry 296, pages 100416.
Crossref
Crossref
Masoumehossadat Hosseini, Navid Rabiee & Mojtaba Bagherzadeh. 2021. Biomedical Applications of Microfluidic Devices. Biomedical Applications of Microfluidic Devices
289
318
.
Christopher Ma & Remo Panaccione. (2020) Harnessing localised delivery of gut-selective therapy for ulcerative colitis. The Lancet Gastroenterology & Hepatology 5:12, pages 1031-1032.
Crossref
Crossref
Ferdinando D'Amico, Giulia Roda, Laurent Peyrin-Biroulet & Silvio Danese. (2019) Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?. Current Pharmaceutical Design 25:1, pages 19-24.
Crossref
Crossref
S. K. MiroshnichenkoO. A. PatutinaE. A. BurakovaB. P. ChelobanovA. A. FokinaV. V. VlassovS. Altman, M. A. ZenkovaD. A. Stetsenko. (2019) Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties. Proceedings of the National Academy of Sciences 116:4, pages 1229-1234.
Crossref
Crossref
Tamara Pérez-Jeldres, Christopher J Tyler, Joshua D Boyer, Thangaraj Karuppuchamy, Giorgos Bamias, Parambir S Dulai, Brigid S Boland, William J Sandborn, Derek R Patel & Jesús Rivera-Nieves. (2019) Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts. Inflammatory Bowel Diseases 25:2, pages 270-282.
Crossref
Crossref
Bo Shen. 2019. Pouchitis and Ileal Pouch Disorders. Pouchitis and Ileal Pouch Disorders
343
356
.
S. R. Brown, N. S. Fearnhead, O. D. Faiz, J. F. Abercrombie, A. G. Acheson, R. G. Arnott, S. K. Clark, S. Clifford, R. J. Davies, M. M. Davies, W. J. P. Douie, M. G. Dunlop, J. C. Epstein, M. D. Evans, B. D. George, R. J. Guy, R. Hargest, A. B. Hawthorne, J. Hill, G. W. Hughes, J. K. Limdi, C. A. Maxwell‐Armstrong, P. R. O'Connell, T. D. Pinkney, J. Pipe, P. M. Sagar, B. Singh, M. Soop, H. Terry, J. Torkington, A. Verjee, C. J. Walsh, J. H. Warusavitarne, A. B. Williams, G. L. Williams & R. G. Wilson. (2018) The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Disease 20:S8, pages 3-117.
Crossref
Crossref
Mark A. Samaan, Bo Shen, Mahmoud H. Mosli, Guangyong Zou, William J. Sandborn, Lisa M. Shackelton, Sigrid Nelson, Larry Stitt, Stuart Bloom, Darrell S. Pardi, Paolo Gionchetti, James Lindsay, Simon Travis, Ailsa Hart, Mark S. Silverberg, Brian G. Feagan, Geert R. D’Haens & Vipul Jairath. (2018) Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointestinal Endoscopy 88:2, pages 360-369.e2.
Crossref
Crossref
Belal Chami, Nathan J.J. Martin, Joanne M. Dennis & Paul K. Witting. (2018) Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease. Archives of Biochemistry and Biophysics 645, pages 61-71.
Crossref
Crossref